UNSPSC 51281611: Dihydrostreptomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H41N7O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P2I6R8W6UA, chemically known as streptomycin, dihydro- but generally known as dihydrostreptomycin, which bears US NIH Compound Identifier 31406. European Medicines Agency schedules Dihydrostreptomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07140MIG.

World Health Organization schedules dihydrostreptomycin in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIHYDROSTREPTOMYCIN remains the US FDA Preferred Term for this commodity. Dihydrostreptomycin bears US NLM identifiers UMLS ID C0262967 and NCI Concept Code C61724. SMILES: O(C1OC(C(O)(C1OC1OC(C(O)C(O)C1NC)CO)CO)C)C1C(/N=C(/N)N)C(O)C(/N=C(/N)N)C(O)C1O.

UNSPSC 51281611 Dihydrostreptomycin is a Commodity code that captures pharmaceutical products procured by state and local health agencies, though recent solicitation activity under this specific code shows minimal alignment with the nominal commodity name. State and local health departments and county public health authorities use this code to source pharmaceuticals and medical supplies for emergency response, disease control, and community health initiatives. The scope of work encompasses the supply and delivery of regulated pharmaceutical products and related health-safety equipment, with vendors typically required to meet federal compliance standards including E-Verify employment verification, drug-free workplace certification, and adherence to federal environmental and procurement regulations.

The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies in recent activity. Illinois awarded a $2,999,999.11 piggyback pharmaceutical supply contract through the MMCAP Infuse cooperative to Chartwell Rx LLC in August 2026 for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) with a 12-month initial term and two renewal options; this was a completed Invitation for Bid award, not an open solicitation. Seminole County posted an IFB in June 2026 (due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, though the substance and scope of these opportunities diverge substantially from the code's stated commodity name, suggesting either code-tagging inconsistency or a shift in state and local procurement patterns under this classification.